	Ruben Dagda Pittsburgh Medical Technology Examiner \| Bio My Bio Subscribe RSS Feed Favorites

Find out more about Ruben:

Ruben Dagda, Ph.D. has authored multiple research manuscripts and review articles in the areas of toxicology and neurobiology. As a research associate and an educator at the University of Pittsburgh, he is interested in enhancing public awareness on the benefits of biomedical research in improving the quality of life, and understanding brain-related diseases. He has presented his research at national conferences and has received numerous awards for his contributions to Parkinson's disease.

Subscribe to Ruben's Email Alerts

Get alerts when Ruben submits a new article

Ruben has been added to your favorite examiners

View my favorite Examiners

Pittsburgh Medical Technology Examiner's Articles

Showing: Pharmacology articles

Magnetic nanoparticles can efficiently locate and destroy tumors

Since their inception, nanoparticles are not just a wonderful chemical engineering invention that have a myriad of possible biomedical applications,...
Keep Reading »

Exercise delays neuronal death and improves quality of life in Parkinson's disease animal models.

Groundbreaking research performed in rhesus macaque monkeys and in rodents showed the benefits of exercise in a neurotoxin model of Parkinson’s...
Keep Reading »

Promising new clinical trials will test whether antioxidants slow progression of Parkinson's disease

More hope is on the way for Parkinson's disease (PD) patients. A large multi-scale Phase III clinical trial study will be conducted by many academic...
Keep Reading »

The FDA may “weight” on the future of the weight-loss drug Alli in the United States

2 comments

Nowadays, there are many weight loss drugs available in the markets that are not regulated by the FDA (ie, hydroxycitric acid, high caffeine and green...
Keep Reading »

Fatostatin, a new weight lowering drug, turns off fat genes in mice; a promising therapy for obesity

Over the last decade, there has been a trend towards an increase in the number and percentage of Americans in the US population that are classified as...
Keep Reading »

Eli Lilly pulls the plug on arzoxifene, a promising anti-osteoporosis and anti-breast cancer drug.

4 comments

In a major but unanticipated move by the pharmaceutical company Eli Lilly, the Indiana based company just decided to pull the promising...
Keep Reading »

Advances in aging research: why methionine restriction is an attractive life-extension strategy

Thus far, caloric restriction may be the most robust and convincing anti-aging intervention known so far, at least as observed in multiple animal...
Keep Reading »

Science fiction? Aerosol delivery of an engineered virus halts lung cancer progression in mice

Nasal sprays containing special viruses may revolutionize the field of pharmacology to correct a multitude of devastating genetic and sporadic human...
Keep Reading »

Grim report: the use of stimulant medications may increase the risk of sudden death in teens

2 comments

There has been an increased incidence of sudden or unexplained deaths in young adults related to use of medical prescribed stimulants or depressants;...
Keep Reading »

Just in: the psoriasis drug Raptiva has been banned in Europe

2 comments

In a manner similar to the COX inhibitor Vioxx, Raptiva became the latest victim of the pharmaceutical industry world-wide due to the development of...
Keep Reading »